
Keywords: asTF; alternatively spliced Tissue Factor; ECRF; immortalized human umbilical vein endothelial cells; ER; endoplasmic reticulum; FVIIa; activated coagulation factor VII; FXa; activated coagulation factor X; flTF; full length Tissue Factor; HUVEC; human um